Literature DB >> 15930052

Competing paradigms of response to assisted suicide requests in Oregon.

N Gregory Hamilton1, Catherine A Hamilton.   

Abstract

Keywords:  Death and Euthanasia

Mesh:

Year:  2005        PMID: 15930052     DOI: 10.1176/appi.ajp.162.6.1060

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Physician-assisted suicide and euthanasia: can you even imagine teaching medical students how to end their patients' lives?

Authors:  J Donald Boudreau
Journal:  Perm J       Date:  2011

2.  Legal physician-assisted dying in Oregon and the Netherlands: evidence concerning the impact on patients in "vulnerable" groups.

Authors:  Margaret P Battin; Agnes van der Heide; Linda Ganzini; Gerrit van der Wal; Bregje D Onwuteaka-Philipsen
Journal:  J Med Ethics       Date:  2007-10       Impact factor: 2.903

Review 3.  Physician-assisted suicide: a review of the literature concerning practical and clinical implications for UK doctors.

Authors:  Madelyn Hsiao-Rei Hicks
Journal:  BMC Fam Pract       Date:  2006-06-22       Impact factor: 2.497

4.  Unbearable suffering and requests for euthanasia prospectively studied in end-of-life cancer patients in primary care.

Authors:  Cees Dm Ruijs; Gerrit van der Wal; Ad Jfm Kerkhof; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2014-12-23       Impact factor: 3.234

5.  Euthanasia and physician-assisted suicide in patients suffering from psychiatric disorders: a cross-sectional study exploring the experiences of Dutch psychiatrists.

Authors:  Kirsten Evenblij; H Roeline W Pasman; Rosalie Pronk; Bregje D Onwuteaka-Philipsen
Journal:  BMC Psychiatry       Date:  2019-02-19       Impact factor: 3.630

6.  Symptoms, unbearability and the nature of suffering in terminal cancer patients dying at home: a prospective primary care study.

Authors:  Cees D M Ruijs; Ad J F M Kerkhof; Gerrit van der Wal; Bregje D Onwuteaka-Philipsen
Journal:  BMC Fam Pract       Date:  2013-12-28       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.